Literature DB >> 22847975

Proteomics tackling schizophrenia as a pathway disorder.

Daniel Martins-de-Souza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22847975      PMCID： PMC3494040          DOI： 10.1093/schbul/sbs094

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  12 in total

1.  Puzzling over schizophrenia: schizophrenia as a pathway disease.

Authors:  Patrick F Sullivan
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

2.  From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis.

Authors:  M R Wilkins; C Pasquali; R D Appel; K Ou; O Golaz; J C Sanchez; J X Yan; A A Gooley; G Hughes; I Humphery-Smith; K L Williams; D F Hochstrasser
Journal:  Biotechnology (N Y)       Date:  1996-01

Review 3.  The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.

Authors:  Daniel Martins-de-Souza; Laura W Harris; Paul C Guest; Sabine Bahn
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

4.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Authors:  C A Tamminga; G K Thaker; R Buchanan; B Kirkpatrick; L D Alphs; T N Chase; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1992-07

5.  Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia.

Authors:  Emanuel Schwarz; Rauf Izmailov; Michael Spain; Anthony Barnes; James P Mapes; Paul C Guest; Hassan Rahmoune; Sandra Pietsch; F Markus Leweke; Matthias Rothermundt; Johann Steiner; Dagmar Koethe; Laura Kranaster; Patricia Ohrmann; Thomas Suslow; Yishai Levin; Bernhard Bogerts; Nico Jm van Beveren; George McAllister; Natalya Weber; David Niebuhr; David Cowan; Robert H Yolken; Sabine Bahn
Journal:  Biomark Insights       Date:  2010-05-12

Review 6.  Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia.

Authors:  Daniel Martins-de-Souza
Journal:  J Psychiatr Res       Date:  2009-08-21       Impact factor: 4.791

Review 7.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

Review 8.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

Review 9.  Proteome analysis of schizophrenia brain tissue.

Authors:  Daniel Martins-De-Souza; Emmanuel Dias-Neto; Andrea Schmitt; Peter Falkai; Philipp Gormanns; Giuseppina Maccarrone; Christoph W Turck; Wagner F Gattaz
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

10.  Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.

Authors:  D Martins-de-Souza; P C Guest; L W Harris; N Vanattou-Saifoudine; M J Webster; H Rahmoune; S Bahn
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222
View more
  9 in total

Review 1.  Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Authors:  Geraldo F Busatto
Journal:  Schizophr Bull       Date:  2013-04-24       Impact factor: 9.306

2.  Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Andrea Schmitt; Peter Falkai; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-01       Impact factor: 5.270

3.  Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients.

Authors:  A Hatzimanolis; J A McGrath; R Wang; T Li; P C Wong; G Nestadt; P S Wolyniec; D Valle; A E Pulver; D Avramopoulos
Journal:  Transl Psychiatry       Date:  2013-05-28       Impact factor: 6.222

Review 4.  Biomarkers in schizophrenia: a brief conceptual consideration.

Authors:  Cynthia S Weickert; Thomas W Weickert; Anil Pillai; Peter F Buckley
Journal:  Dis Markers       Date:  2013-07-21       Impact factor: 3.434

Review 5.  Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes.

Authors:  A P Mullin; A Gokhale; A Moreno-De-Luca; S Sanyal; J L Waddington; V Faundez
Journal:  Transl Psychiatry       Date:  2013-12-03       Impact factor: 6.222

Review 6.  The proteome of schizophrenia.

Authors:  Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  NPJ Schizophr       Date:  2015-03-04

7.  Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response.

Authors:  Daniel Martins-de-Souza; Fiorella A Solari; Paul C Guest; René P Zahedi; Johann Steiner
Journal:  NPJ Schizophr       Date:  2015-12-09

8.  Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT.

Authors:  Vanja Dakic; Juliana Minardi Nascimento; Rafaela Costa Sartore; Renata de Moraes Maciel; Draulio B de Araujo; Sidarta Ribeiro; Daniel Martins-de-Souza; Stevens K Rehen
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

Review 9.  Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research.

Authors:  Melanie J Grubisha; Robert A Sweet; Matthew L MacDonald
Journal:  Front Mol Neurosci       Date:  2021-07-16       Impact factor: 5.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.